Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06114849 · ClinicalTrials.gov registry record · NA
Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 3)
A NA study, sponsored by Harvard University.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT06114849 is a NA study that was terminated before completion, run by Harvard University. The registered enrollment target is 29 participants.
The verdict
NCT06114849, a NA study, was terminated before completion, sponsored by Harvard University.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This clinical trial is part of a series of brief interventions to reduce suicide risk in collaboration with the social media platform RallyPoint, a site specifically designed for U.S. servicemembers and veterans to connect with one another. In this RCT (Intervention 3: Professional Outreach), the investigators will test a psychoeducational intervention aimed at increasing users' likelihood of reaching out to mental health resources (e.g., suicide hotline) when experiencing distress.
Interventions
- BEHAVIORAL Treatment as usual
- BEHAVIORAL Barrier Reduction Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2023-11-20 |
| Est. Completion | 2025-03-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06114849
The ClinicalTrials.gov registry entry for NCT06114849 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as usual is the first listed.
NCT06114849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06114849 about?
NCT06114849 is a clinical study titled "Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 3)". This clinical trial is part of a series of brief interventions to reduce suicide risk in collaboration with the social media platform RallyPoint, a site specifically designed for U.S. servicemembers and veterans to connect with one another. In this RCT (Intervention 3: Professional Outreach), the in...
What is the current status of trial NCT06114849?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2023-11-20. Estimated completion is 2025-03-14.
What interventions are being tested in trial NCT06114849?
The interventions under investigation include: Treatment as usual (BEHAVIORAL), Barrier Reduction Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06114849?
This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.